During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …

Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …

The search for the genetic factors contributing to Alzheimer disease (AD) has evolved
tremendously throughout the years. It started from the discovery of fully penetrant mutations …

Background: Timely diagnosis of Alzheimer's disease (AD) refers to a diagnosis at the stage
when patients come to the attention of clinicians because of concerns about changes in …

In the 12 years since the publication of the first Consensus Paper of the WFSBP on
biomarkers of neurodegenerative dementias, enormous advancement has taken place in …

A comprehensive guide to privileged structures and their application in the discovery of new
drugs The use of privileged structures is a viable strategy in the discovery of new medicines …

Alzheimer's disease (AD) is a neurological condition that worsens with ageing and affects
memory and cognitive function. Presently more than 55 million individuals are affected by …

Purpose In the last decade, the research community has focused on defining reliable
biomarkers for the early detection of Alzheimer's disease (AD) pathology. In 2017, the …

Abstract Background The NIA-AA research framework proposes a purely biological
definition of Alzheimer's disease (AD). This implies that AD can be diagnosed based on …

Alzheimer's disease (AD) is the most common type of dementia among individuals 65 or
older. There are more than 5 million diagnosed cases in the US alone and this number is …